Cc1cc(CN(C)C(=O)CC2C(=O)NCCN2Cc2c(F)cccc2Cl)n[nH]1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?